BIOMAT Database Logo BIOMAT Database Logo

Kinetic studies of tyrosine kinase inhibition by erbstatin. 1987

M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Institute of Microbial Chemistry, Tokyo, Japan.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D011505 Protein-Tyrosine Kinases Protein kinases that catalyze the PHOSPHORYLATION of TYROSINE residues in proteins with ATP or other nucleotides as phosphate donors. Tyrosine Protein Kinase,Tyrosine-Specific Protein Kinase,Protein-Tyrosine Kinase,Tyrosine Kinase,Tyrosine Protein Kinases,Tyrosine-Specific Protein Kinases,Tyrosylprotein Kinase,Kinase, Protein-Tyrosine,Kinase, Tyrosine,Kinase, Tyrosine Protein,Kinase, Tyrosine-Specific Protein,Kinase, Tyrosylprotein,Kinases, Protein-Tyrosine,Kinases, Tyrosine Protein,Kinases, Tyrosine-Specific Protein,Protein Kinase, Tyrosine-Specific,Protein Kinases, Tyrosine,Protein Kinases, Tyrosine-Specific,Protein Tyrosine Kinase,Protein Tyrosine Kinases,Tyrosine Specific Protein Kinase,Tyrosine Specific Protein Kinases
D006873 Hydroquinones Derivatives of hydroquinone (1,4-dihydrobenzene) made by reduction of BENZOQUINONES. Quinol,p-Dihydroxybenzenes,para-Dihydroxybenzenes,Quinols,p Dihydroxybenzenes,para Dihydroxybenzenes
D066246 ErbB Receptors A family of structurally related cell-surface receptors that signal through an intrinsic PROTEIN-TYROSINE KINASE. The receptors are activated upon binding of specific ligands which include EPIDERMAL GROWTH FACTORS, and NEUREGULINS. EGF Receptor,Epidermal Growth Factor Receptor,Epidermal Growth Factor Receptor Family Protein,Epidermal Growth Factor Receptor Protein-Tyrosine Kinase,ErbB Receptor,HER Family Receptor,Receptor, EGF,Receptor, Epidermal Growth Factor,Receptor, TGF-alpha,Receptor, Transforming-Growth Factor alpha,Receptor, Urogastrone,Receptors, Epidermal Growth Factor-Urogastrone,TGF-alpha Receptor,Transforming Growth Factor alpha Receptor,Urogastrone Receptor,c-erbB-1 Protein,erbB-1 Proto-Oncogene Protein,EGF Receptors,Epidermal Growth Factor Receptor Family Proteins,Epidermal Growth Factor Receptor Kinase,HER Family Receptors,Proto-oncogene c-ErbB-1 Protein,Receptor Tyrosine-protein Kinase erbB-1,Receptor, ErbB-1,Receptors, Epidermal Growth Factor,Epidermal Growth Factor Receptor Protein Tyrosine Kinase,ErbB-1 Receptor,Family Receptor, HER,Family Receptors, HER,Proto oncogene c ErbB 1 Protein,Proto-Oncogene Protein, erbB-1,Receptor Tyrosine protein Kinase erbB 1,Receptor, ErbB,Receptor, ErbB 1,Receptor, HER Family,Receptor, TGF alpha,Receptor, Transforming Growth Factor alpha,Receptors, EGF,Receptors, Epidermal Growth Factor Urogastrone,Receptors, ErbB,Receptors, HER Family,c erbB 1 Protein,c-ErbB-1 Protein, Proto-oncogene,erbB 1 Proto Oncogene Protein

Related Publications

M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Inhibition of protein kinase C by the tyrosine kinase inhibitor erbstatin.
November 1990, Biochemical pharmacology,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Inhibition of angiogenesis by erbstatin, an inhibitor of tyrosine kinase.
May 1993, The Journal of antibiotics,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Inhibition of serum-induced M-phase progression by a tyrosine kinase inhibitor, erbstatin.
July 1993, Biochemical and biophysical research communications,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Selective inhibition of human neutrophil functional responsiveness by erbstatin, an inhibitor of tyrosine protein kinase.
November 1990, Blood,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Limited selectivity of a synthetic erbstatin derivative for tyrosine kinase and cell growth inhibition.
March 1992, Biochemistry international,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Inhibition kinetics and selectivity of the tyrosine kinase inhibitor erbstatin and a pyridone-based analogue.
June 1992, Biochemical pharmacology,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Age-dependent differences in the inhibition of HCN2 current in rat ventricular myocytes by the tyrosine kinase inhibitor erbstatin.
February 2009, Pflugers Archiv : European journal of physiology,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Evidence for an erbstatin-sensitive tyrosine kinase functioning in ascidian egg activation.
September 1997, Biochemical and biophysical research communications,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Kinetic studies on the inhibition of nucleoside diphosphate kinase by desdanine.
September 1974, Journal of biochemistry,
M Imoto, and K Umezawa, and K Isshiki, and S Kunimoto, and T Sawa, and T Takeuchi, and H Umezawa
Inhibition of Abelson oncogene function by erbstatin analogues.
January 1993, Drugs under experimental and clinical research,
Copied contents to your clipboard!